The AMPK/ULK1/p27Kip1 axis regulates autophagy and cell survival in aged satellite cells

AMPK/ULK1/p27Kip1 轴调节衰老卫星细胞的自噬和细胞存活

基本信息

  • 批准号:
    10177828
  • 负责人:
  • 金额:
    $ 12.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-15 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

a. Project summary/abstract: Sarcopenia is the age-related loss in skeletal muscle mass and strength; it leads to a host of co-morbidities including loss of physical function and overall resilience. One such perturbation in persons with sarcopenia is the diminished ability to regenerate muscle after injury. Muscle stem cells, referred to as satellite cells, are required to activate, proliferate and differentiate to regenerate muscle and restore physical function. Aged satellite cells are slower to activate upon injury; susceptible to apoptosis; and less efficient in repairing injured muscle. The AMPK/ULK1/p27Kip1 pathway appears critical for successful transition from quiescence to entry into the cell cycle. Our preliminary data identify perturbations in the AMPK/ULK1/p27Kip1 pathway with advanced age. This award period will investigate the role of the AMPK/ULK1/p27Kip1 pathway in the phenotype of satellite cell aging in both human and mouse models. In Aim1, we will test the hypothesis that activation of AMPK and its downstream targets ULK1 and p27Kip1 regulate the autophagy/apoptosis decision in aged satellite cells. We will use molecular assays to rescue the functional loss of this pathway in aged cells and return proliferative capacity. In Aim 2, we will test the hypothesis that exercise, a physiological inducer of AMPK and autophagy, stimulates the AMPK/ULK1/p27Kip1 pathway, thereby enhancing proliferation and metabolic function in aging murine and human satellite cells. Aim 3 will test the hypothesis that AMPK/ULK1/p27Kip1 signaling will regulate the beneficial effects of caloric restriction on aged satellite cells. Together, the experiments in this proposal will test the hypothesis that the AMPK/ULK1/p27Kip1 pathway is impaired in aging satellite cells resulting in a reduction in autophagy and susceptibility to apoptosis. Key aspects of Dr. White's career enhancement will be: to learn how to coordinate clinical exercise trials; to train in methods of satellite cell isolation and metabolic analysis, especially in the context of the aging organism. The training program will entail dedicated internal and external scientific presentations; pertinent course work/workshops in stem cell biology and aging; and intensive career mentorship to ensure progress toward independence. The research and career development plan detailed in this proposal will be conducted with a team of outstanding mentors. Dr. William E. Kraus, a professor at the Duke Medical School is an established expert in clinical exercise studies and muscle/satellite cell biology; he will serve as the primary mentor. Drs. Kenneth Schmader, Deborah Muoio (Duke) and Amy Wagers (Harvard) will serve as co-mentors; they will facilitate training in aging biology, cell metabolism and aging stem cell biology, respectively. The environment at the Duke School of Medicine is ideal for the research and training activities outlined in this proposal. This award will provide Dr. White with optimal training to ensure an outstanding start to his career as an independent investigator.
a.项目总结/摘要: 肌肉减少症是与年龄相关的骨骼肌质量和力量的损失;它导致了一系列的合并症 包括身体功能和整体恢复力的丧失。在肌肉减少症患者中的一种这样的扰动是 受伤后肌肉再生能力减弱。肌肉干细胞,被称为卫星细胞, 需要激活,增殖和分化,以再生肌肉和恢复身体功能。岁 卫星细胞在损伤后激活较慢;易于凋亡;并且在修复损伤中效率较低 肌肉. AMPK/ULK 1/p27 Kip 1通路对于从静止到进入的成功转变似乎是关键的 进入细胞周期。我们的初步数据确定了AMPK/ULK 1/p27 Kip 1通路的扰动, 高龄该奖项期间将研究AMPK/ULK 1/p27 Kip 1通路在细胞凋亡中的作用。 在人类和小鼠模型中的卫星细胞衰老表型。在Aim 1中,我们将测试以下假设: AMPK及其下游靶点ULK 1和p27 Kip 1的激活调节自噬/凋亡决定 在老化的卫星细胞中我们将使用分子检测来挽救衰老细胞中这一通路的功能丧失 恢复增殖能力。在目标2中,我们将检验这样一个假设,即运动是一种生理诱导剂, AMPK和自噬,刺激AMPK/ULK 1/p27 Kip 1通路,从而增强增殖, 衰老的小鼠和人类卫星细胞的代谢功能。目标3将检验以下假设: AMPK/ULK 1/p27 Kip 1信号通路将调节热量限制对衰老卫星细胞的有益作用。 总之,本提案中的实验将检验AMPK/ULK 1/p27 Kip 1通路是 在老化的卫星细胞中受损,导致自噬减少和对凋亡的敏感性。关键 白色的职业发展方面将是:学习如何协调临床运动试验;培训 在卫星细胞分离和代谢分析方法中,特别是在衰老生物体的背景下。 培训计划将包括专门的内部和外部科学演示;相关课程 干细胞生物学和衰老方面的工作/研讨会;以及密集的职业指导,以确保 独立本建议书中详细说明的研究和职业发展计划将通过以下方式进行: 优秀的导师团队。William E.克劳斯是杜克医学院的教授, 临床运动研究和肌肉/卫星细胞生物学专家;他将担任主要导师。Drs. Kenneth Schmader,Deborah Muoio(杜克)和Amy Wagers(哈佛)将担任共同导师;他们将 分别促进老化生物学、细胞代谢和老化干细胞生物学的培训。环境 在杜克医学院是理想的研究和培训活动中概述了这一建议。这 该奖项将为白色博士提供最佳培训,以确保他的职业生涯有一个出色的开端, 独立调查员

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James P. White其他文献

Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia
雄性 ApcMin/ 小鼠作为与癌症恶病质相关的性腺机能减退模型的表征
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    James P. White;Melissa J. Puppa;Aditi A. Narsale;J. Carson
  • 通讯作者:
    J. Carson
Career pathways, part 6
职业发展路径,第 6 部分
  • DOI:
    10.1038/s42255-021-00475-8
  • 发表时间:
    2021-10-07
  • 期刊:
  • 影响因子:
    20.800
  • 作者:
    James P. White;Wenjing Du
  • 通讯作者:
    Wenjing Du
Coordination chemistry of lanthanides with transition metal anions
镧系元素与过渡金属阴离子的配位化学
  • DOI:
    10.1016/s0925-8388(96)02747-8
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    S. Shore;David W. Knoeppel;H. Deng;Jianping Liu;James P. White;S. Chun
  • 通讯作者:
    S. Chun
The Regulation of Skeletal Muscle Protein Turnover During the Progression of Cancer Cachexia in the <em>Apc<sup>Min/+</sup></em> Mouse
<em>Apc<sup>Min/ </sup></em>小鼠癌症恶病质进展过程中骨骼肌蛋白周转的调节
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    James P. White;J. Baynes;S. Welle;M. Kostek;L. Matesic;Shuichi;Sato;J. Carson
  • 通讯作者:
    J. Carson
Control of Skeletal Muscle Cell Growth and Size Through Adhesion GPCRs.
通过粘附 GPCR 控制骨骼肌细胞生长和大小。

James P. White的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James P. White', 18)}}的其他基金

Assessing healthspan and epigenetics in aged mice after prolonged exposure to young circulation
评估长期暴露于年轻循环后的老年小鼠的健康寿命和表观遗传学
  • 批准号:
    9979231
  • 财政年份:
    2020
  • 资助金额:
    $ 12.25万
  • 项目类别:
Assessing healthspan and epigenetics in aged mice after prolonged exposure to young circulation
评估长期暴露于年轻循环后的老年小鼠的健康寿命和表观遗传学
  • 批准号:
    10263935
  • 财政年份:
    2020
  • 资助金额:
    $ 12.25万
  • 项目类别:
The AMPK/ULK1/p27Kip1 axis regulates autophagy and cell survival in aged satellite cells
AMPK/ULK1/p27Kip1 轴调节衰老卫星细胞的自噬和细胞存活
  • 批准号:
    10184129
  • 财政年份:
    2017
  • 资助金额:
    $ 12.25万
  • 项目类别:
The AMPK/ULK1/p27Kip1 axis regulates autophagy and cell survival in aged satellite cells
AMPK/ULK1/p27Kip1 轴调节衰老卫星细胞的自噬和细胞存活
  • 批准号:
    10600362
  • 财政年份:
    2017
  • 资助金额:
    $ 12.25万
  • 项目类别:
The AMPK/ULK1/p27Kip1 axis regulates autophagy and cell survival in aged satellite cells
AMPK/ULK1/p27Kip1 轴调节衰老卫星细胞的自噬和细胞存活
  • 批准号:
    9371401
  • 财政年份:
    2017
  • 资助金额:
    $ 12.25万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 12.25万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了